IL13RA2 and neoplasm: The study demonstrated that these scFv-IL-13Rα2-CAR-T cells exhibited significant antitumor activity in vitro and in vivo, effectively killing IL-13Rα2-positive tumor cells while showing low toxicity in non-tumor-bearing mice [100].